CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Conditions:
🦠 Alopecia Areata
🗓️ Study Start (Actual) 25 October 2022
🗓️ Primary Completion (Estimated) 31 December 2099
✅ Study Completion (Estimated) 31 December 2099
👥 Enrollment (Estimated) 5000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Waltham, Massachusetts, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * A subject must meet all the following criteria to participate in the registry:
    • 1. Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner.
    • 2. Is at least 18 years of age or older.
    • 3. Is willing to provide Personal Information.
    • 4. Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.

    Exclusion Criteria:

    • * Any of the following would exclude the subject from participating in the registry:
    • 1. Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note:
    • Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 16 February 2023
  • First Submitted that Met QC Criteria 16 February 2023
  • First Posted 27 February 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 15 July 2024
  • Last Update Posted 16 July 2024
  • Last Verified April 2024